Given the strong association of DPP6 with Alzheimer’s disease and frontotemporal dementia, as well as the shared features among ALS, MS, and SBMA, it is worth considering whether these complex neurodegenerative diseases share a common molecular mechanism potentially linked to DPP6 dysfunction. Here, DPP6 is linked to myeloid sarcoma.